Adlon Therapeutics L.P. Announces Two New Publications of Adhansia XR® (methylphenidate HCl) Extended-Release Capsules CII Data

Autor: Adlon Therapeutics L.P.
Zdroj: Business Wire (English). 11/18/2020.
Abstrakt: Adlon Therapeutics L.P., a subsidiary of Purdue Pharma L.P., announced two recent online publications of studies related to the efficacy, safety and pharmacokinetics of Adhansia XR® (methylphenidate hydrochloride) extended-release capsules CII (investigationally known as PRC-063). [ABSTRACT FROM PUBLISHER]
Databáze: Regional Business News
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje